Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Aug;56(2):106043.
doi: 10.1016/j.ijantimicag.2020.106043. Epub 2020 Jun 2.

Tocilizumab administration in a refractory case of COVID-19

Farzaneh Dastan  1 , Seyed Alireza Nadji  2 , Ali Saffaei  3 , Payam Tabarsi  4
Affiliations
Case Reports

Tocilizumab administration in a refractory case of COVID-19

Farzaneh Dastan et al. Int J Antimicrob Agents. 2020 Aug.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Fig. 1
Chest X-ray of the patient during hospitalization. (a, b and c) Progression of lower and upper lobe infiltration. (d, e and f) Recovery of infiltration after tocilizumab administration.
Figure 2
Fig. 2
Timeline of vital signs, therapeutic regimens, and laboratory results during hospitalization.
See this image and copyright information in PMC

References

    1. Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DKW, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2020;25 - PMC - PubMed
    1. Zhang C, Wu Z, Li J-W, Zhao H, Wang G-Q. The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality. Int J Antimicrob Agents. 2020 - PMC - PubMed
    1. Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Sevestre J, et al. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study. Travel Med Infect Dis. 2020;34 - PMC - PubMed
    1. Hammami MB, Garibaldi B, Shah P, Liu G, Jain T, Chen PH, et al. Clinical Course of COVID-19 in a Liver Transplant Recipient on Hemodialysis and Response to Tocilizumab Therapy: A Case Report. 2020. - PMC - PubMed
    1. Sciascia S, Apra F, Baffa A, Baldovino S, Boaro D, Boero R, et al. Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19. Clin Exp Rheumatol. 2020 - PubMed

MeSH terms